CD8A and neoplasm: A recent work by Adhikari et al. [105] reports the design of a multi-epitope DNA vaccine using a universal intracellular targeted expression (UNITE) platform, which involves the fusion of antigens to LAMP1 with the aim of improving CD4 and CD8 mediated anti-tumor responses.